P1225: SECONDARY PRIMARY MALIGNANCIES (SPM) AFTER HIGH-DOSE CHEMOTHERAPY (HDT) WITH AUTOLOGOUS STEM CELL TRANSPLANT (ASCT) FOR LYMPHOMA: A DANISH NATIONWIDE COHORT STUDY
Trine Trab(University of Copenhagen), Tarec Christoffer El‐Galaly(Aalborg University Hospital), Karin E. Smedby(Karolinska Institutet), Thomas Stauffer Larsen(Odense University Hospital), Jette Sønderskov Gørløv(Copenhagen University Hospital), Peter de Nully Brown(Copenhagen University Hospital), Marianne Tang Severinsen(Aalborg University Hospital), S. Gudbrandsdottir(Zealand University Hospital), Sandra Eloranta(Karolinska Institutet), Simon Husby(Copenhagen University Hospital), Joachim Bæch(Aalborg University Hospital), Judit Jørgensen(Aarhus University Hospital), Lasse Hjort Jakobsen(Aalborg University Hospital)
Cited by 0
Related Papers
Etiologic Heterogeneity Among Non-Hodgkin Lymphoma Subtypes: The InterLymph Non-Hodgkin Lymphoma Subtypes Project
|JNCI Monographs|2014|334
Adaptation of the Charlson Comorbidity Index for Register-Based Research in Sweden
|Clinical Epidemiology|2021|267
Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia
|Nature Genetics|2013|211
Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations
|Blood|2015|154
Dietary Factors and Risk of Non-Hodgkin Lymphoma in Men and Women
|Cancer Epidemiology Biomarkers & Prevention|2005|100